50% off Premium Yearly
Equinox GoldEQX.TOBUYAug 08, 2019Stock price when the opinion was issued
As of Jun 19, 2026. Market Open.
Underperformed because of operational difficulty in existing deposits and because of current large build in Ontario. Ontario and Quebec have an abysmal record for being on time or on budget. He thinks they'll make it and then the stock will rerate substantially. No dividend.
(Analysts’ price target is $8.11)Trapped in a base for most of 2022. Now breaking out, and that's being tested. As long as it successfully holds around $6, you're good to go. If it breaks for a number of days, get out. If it bounces from $6 and lasts a few days, he'd rather buy around $6.20 than buy today and watch it break. Not a bad-looking chart for a trade.
Prospects are hinging on hard rock deposits in Ontario. Past projects not completed on time. Believes the company will be able to complete on time and on budget. If so, the stock will get a rerating. Team is led by Ross Beatty who he has done business with for many years. They have a graest track record.
EPS of $0.027 beat estimates of ($0.044) and revenues of $352.16M missed expectations of $361.39M.
The stock rose as better-than-expected adjusted EBITDA helped to lift the name and as its guidance for CAPEX was less than expected.
Management noted this was its strong quarter of production at the lowest costs for the year.
Significant progress was made at its mines and it is well-funded to complete construction at Greenstone for the first half of 2024.
The results largely looked strong, but the name has not held up as well as the underlying price of gold and the company's debt levels are quite high. We would consider it to be OK at current levels, although its high leverage does present some level of concern for us.
Unlock Premium - Try 5i Free
If it's gold, you have to own it. Don't worry if it doesn't have any earnings now. Underwater because of production costs, so they cut and cut. Now the leverage on the growth is unbelievable. Early innings, not too late. (Analysts’ price target is $2.08)